Increased hospital length of stay attributable to Clostridium difficile infection in patients with four co-morbidities: An analysis of hospital episode statistics in four European countries

European Journal of Health Economics

Volumn 14, Issue 5, 2013, Pages 835-846

  Eckmann, Christian ^a   Wasserman, Matthew ^b   Latif, Faisal ^b   Roberts, Graeme ^b   Beriot Mathiot, Axelle ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Double Helix Consulting   (United Kingdom)

^c SANOFI PASTEUR   (France)

Author keywords

Clostridium difficile infection; Clostridium difficile infection outcomes; Europe; Hospital burden; Hospital episode statistics; Hospital length of stay

Indexed keywords

AGED; ARTICLE; BUDGET; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GERMANY; HEART FAILURE; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; NATIONAL HEALTH SERVICE; NETHERLANDS; PRIORITY JOURNAL; PROPENSITY SCORE; RESOURCE ALLOCATION; RISK FACTOR; SPAIN; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMORBIDITY; COST OF ILLNESS; DATABASES, FACTUAL; ENGLAND; EUROPEAN UNION; FEMALE; GERMANY; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; NETHERLANDS; SPAIN;

EID: 84893144134     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-013-0498-8     Document Type: Article

References (39)

1. Kelly, C. P., La Mont, J. T.: Clostridium difficile infection. Annu. Rev. Med. 49, 375-390 (1998)
2. Wiegand, P. M., Nathwani, D., Wilcox, M., Stephens, J., Shelbaya, A., Haider, S.: Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcarefacility-acquired infection. J. Hosp. Infect. 81, 1-14 (2012)
3. Kuijper, E. J., Coignard, B., Tüll, P.: Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 12(Suppl 6), 2-18 (2006)
4. Bauer, M. P., Notermans, D. W., Van Benthem, B. H., Brazier, J. S., Wilcox, M. H., Rupnik, M., Monnet, D. L., Van Dissel, J. T., Kuijper, E. J.: Clostridium difficile infection in Europe: a hospitalbased survey. Lancet 377, 63-73 (2010)
5. Dubberke, E. R., Wertheimer, A. I.: Review of the current literature on the economic burden of Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 30, 57-66 (2009)
6. Kutty, P. K., Woods, C. W., Sena, A. C., Benoit, S. R., Naggie, S., Frederick, J., Evans, S., Engel, J., McDonald, L. C.: Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. Emerg. Infect. Dis. 16, 197-204 (2010)
7. Khanna, S., Pardi, D., Aronson, S., Kammer, P., Orenstein, R., Sauver, J., Harmsen, W., Zinsmeister, A.: The epidemiology of community-acquired Clostridium difficile infection: a population based study. Am. J. Gastroenterol. 107, 89-95 (2012)
8. Kuntz, J. L., Johnson, E. S., Raebel, M. A., et al.: Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect. Control Hosp. Epidemiol. 33(10), 1031-1038 (2012)
9. Rodrigues, M. A., Brady, R. R., Rodrigues, J., Graham, C., Gibb, A. P.: Clostridium difficile infection in general surgery patients; identification of high-risk populations. Int. J. Surg. 8(5), 368-372 (2010). doi:10.1016/j.ijsu. 2010.05.004. Epub2010May24
10. International Classification of Diseases (ICD). World Health Organization. http://www.who.int/classifications/icd/en/. Accessed 29 November 2012
11. O'Brien, J. A., Lahue, B. J., Caro, J. J., Davidson, D. M.: The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect. Control Hosp. Epidemiol. 28, 1219-1227 (2007)
12. Hospital Episode Statistics (HES) (2011) http://www.hesonline. nhs.uk. Accessed 15 December 2011
13. Gesundheitsberichterstattung des Bundes (GdB) (Federal Health Monitoring Database) (2011) http://www.gbe-bund.de/. Accessed 15 December 2011
14. Landelijke Medische Registratie (LMR) (Dutch Hospital Data) (2011). http://www.dutchhospitaldata.nl/. Accessed 15 December 2011
15. Conjunto Minimo Basico de Datos (Minimum Basic Data Set (MBDS)). (2011). http://www.msc.es/estadEstudios/estadisticas/cmbd.htm. Accessed 10 January 2012
16. Rosenbaum, P., Rubin, D.: The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41-50 (1983)
17. Caliendo, M., Kopeinig, S.: Some practical guidance for the implementation of propensity score matching. J. Econ. Surv. 22, 31-72 (2008)
18. Sianesi, B.: An evaluation of the active labour market programmes in Sweden. Rev. Econ. Stat. 86, 133-155 (2004)
19. Macgowan, A., Brown, I., Feeney, R., Lovering, A., Mculloch, S., Reeves, D., Cheesman, M. G., Shetty, H. G., Wilcox, M. H., Cunnliffe, J. G.: Clostridium difficile associated diarrhoea and length of hospital stay. J. Hosp. Infect. 31, 241-244 (1995)
20. Riley, T., Codde, J., Rouse, I.: Increased length of stay due to Clostridium difficile associated diarrhoea. Lancet 345, 455-456 (1995)
21. Wilcox, M., Cunnife, J., Trundle, C., Redpath, C.: Financial burden of hospital-acquired Clostridium difficile infection. J. Hosp. Infect. 34, 23-30 (1996)
22. Plowman, R. P., Graves, N., Griffin, M., Roberts, J. A., Swan, A. V., Cookson, B. C., Taylor, L.: The socioecomic burden of hospital acquired infection. Public Health Laboratory Service, London (1999)
23. Jen, M. H., Saxena, S., Bottle, A., Aylin, P., Pollok, R. C. G.: Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment. Pharmacol. Ther. 33, 1322-1331 (2011). doi:10.1111/j.1365-2036.2011.04661.x
24. Vonberg, R. P., Reichardt, C., Behnke, M., Schwab, F., Zindler, S., Gastmeier, P.: Costs of nosocomial Clostridium difficile-associated diarrhoea. J. Hosp. Infect. 70, 15-20 (2008)
25. Zerey, M., Paton, B. L., Lincourt, A. E., Gersin, K. S., Kercher, K. W., Heniford, B. T.: The burden of Clostridium difficile in surgical patients in the United States. Surg. Infect. (Larchmt). 8, 557-566 (2007)
26. Asensio, A., Vaque-Rafart. J, Calbo-Torrecillas F, Gestal-Otero J, Lopez-Fenandez F, Trilla-Garcia, A:, Canton, R.: Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007. Euro. Surveill. 13
27. Perencevich, E. N., Thorm, K. A.: Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper? Infect. Control Hosp. Epidemiol. 29, 829-831 (2008)
28. Jones, G., Taright, N., Boelle, P. Y., Marty, J., Lalande, V., Eckert, C., Barbut, F.: Accuracy of ICD-10 codes for surveillance of Clostridium difficile infections. France. Emerg. Infect. Dis. 18, 979-981 (2009). doi:10.3201/eid1806.111188
29. Graves, N., Weinhold. D., Tong, E., Birrell, F., Doidge, S., Ramritu, P., Halton, K., Lairson, Whitby M.: Effect of health-acquired infection on length of hospital stay and cost. Infect. Control. Hosp. Epidemiol. 28, 280-292 (2007) doi: 10.1086/512642
30. Dubberke, E., Butler, A., Reske, K., Agniel, D., Olsen, M., D'Angelo, G., McDonald, C., Fraser, V.: Attributable outcome of endemic Clostridium difficile-associated disease in non-surgical patients. Emerg. Infect. Dis. 2008(14), 1031-1038 (2008)
31. Dubberke, E. R., Reske, K. A., Olsen, M. A., McDonald, L. C., Fraser, V. J.: Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin. Infect. Dis. 46, 497-504 (2008)
32. Hardt, C., Berns, T., Treder, W., Dumoulin, F. L.: Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J. Gastroenterol. 14, 338-4341 (2008)
33. Beaujean, D., Blok, H., Gigengack-Baars, A., Kamp-Hopmans, T., Ballemans, K., Verhoef, J., Weersink, A.: Five year surveillance of patients with communicable diseases nursed in isolation. J. Hosp. Infect. 47, 210-217 (2001)
34. Ang, C. W., Heyes, G., Morrison, P., Carr, B.: The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK. J. Infect. 57, 435-440 (2008)
35. Mitu-Pretorian, O. M., Forgacs, B., Qumruddin, A., Tavakoli, A., Augustine, T., Pararajasingam, R.: Outcomes of patients who develop symptomatic Clostridium difficile infection after solid organ transplantation. Transplant. Proc. 42, 2631-2633 (2010)
36. Musa, S. A., Robertshaw, H., Thomson, S. J., Cowan, M. L., Rahman, T. M.: Clostridium difficile-associated disease acquired in the neurocriticalcare unit. Neurocrit. Care 13, 87-92 (2010)
37. Mitchell, B. G., Gardner, A.: Prolongation of length of stay and Clostridium difficile infection: a review of the methods used to examine length of stay due to healthcare associated infections. Antimicrob. Resist. Infect. Control 1, 14 (2012). doi:10.1186/2047-2994-1-14
38. Health Protection Agency (HPA), Department of Health. Clostridium difficile Infection: how to deal with the problem, pp 2-50. Department of Health, London (2008)
39. Clostridium difficile Infection Facts. (ECDC). European Centre for Disease Prevention and Control (2012). http://ecdc.europa.eu/EN/HEALTHTOPICS/ CLOSTRIDIUM-DIFFICILE-INFECTION/BASIC-FACTS/Pages/basic-facts.aspx. Accessed 28 November 2012